PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28698741-1	2017	AIM: To investigate the association of peroxisome proliferator-activated receptor gamma (PPARG) Pro12Ala polymorphism with polycystic ovary syndrome (PCOS) and its effect on the metabolic parameters in PCOS women.	pro12ala	96-104	peroxisome proliferator activated receptor gamma	Homo sapiens	39-87	
28698741-1	2017	AIM: To investigate the association of peroxisome proliferator-activated receptor gamma (PPARG) Pro12Ala polymorphism with polycystic ovary syndrome (PCOS) and its effect on the metabolic parameters in PCOS women.	pro12ala	96-104	peroxisome proliferator activated receptor gamma	Homo sapiens	89-94	
28698741-2	2017	METHODS: The study used PCR to identify the presence of the PPARG Pro12Ala polymorphism in 100 PCOS women and 120 age-matched healthy women.	pro12ala	66-74	peroxisome proliferator activated receptor gamma	Homo sapiens	60-65	
28698741-4	2017	RESULTS: Significant difference in the genotypes distributions of PPARG Pro12Ala polymorphism was observed among PCOS women and controls (p = 0.03).	pro12ala	72-80	peroxisome proliferator activated receptor gamma	Homo sapiens	66-71	
28698741-7	2017	CONCLUSION: The PPARG Pro12Ala polymorphism might contribute to the risk of PCOS and abnormal metabolic parameters and could be considered as a biomarker for early diagnosis and clinic prediction of metabolic complications.	pro12ala	22-30	peroxisome proliferator activated receptor gamma	Homo sapiens	16-21